Hk Hongmeiren Biological Technology Limited Company Information

Current Status : Live


Hk Hongmeiren Biological Technology Limited's Hong Kong CR Number is 2518231. Incorporation Date is 31-MAR-2017. It's Winding up Mode is . Dissolution date is . Hk Hongmeiren Biological Technology Limited company is of Private company limited by shares Type.
Additional Remarks on the Hk Hongmeiren Biological Technology Limited company are .

Company Data

CRN2518231
Company NameHK HONGMEIREN BIOLOGICAL TECHNOLOGY LIMITED
Chinese Name香港紅美人生物科技有限公司
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up Mode
Date of Incorporation31-MAR-2017
See companies with same Incorporation Date - 31-MAR-2017
Date of Dissolution
Remarks
Important Note
Tagsbiological   technology   hongmeiren   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
HK HONGMEIREN BIOLOGICAL TECHNOLOGY LIMITED31-MAR-2017

FAQs:

When was Hk Hongmeiren Biological Technology Limited incorporated?

Hk Hongmeiren Biological Technology Limited was incorporated on 31-MAR-2017 in Hongkong.

What is the type of Hk Hongmeiren Biological Technology Limited?

Hk Hongmeiren Biological Technology Limited is classified as Private company limited by shares.

What is the current status of Hk Hongmeiren Biological Technology Limited Company?

The status of Hk Hongmeiren Biological Technology Limited is Live.

What is the CR Number of Hk Hongmeiren Biological Technology Limited?

The CR Number of Hk Hongmeiren Biological Technology Limited is 2518231.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Hk Hongmeiren Biological Technology Limited. The official registry should always be referred for latest information.

Last Updated on 21-05-2017.

Check other companies added on 21-05-2017

Check out Companies Incorporated on 31-MAR-2017: